P127<strong>The</strong> effect <strong>of</strong> inhaled carbon dioxide on constricted airways inan animal model <strong>of</strong> asthmaF Green 1 , T El Mays 11 University <strong>of</strong> Calgary<strong>The</strong> objective <strong>of</strong> this study was to determine the effects <strong>of</strong> inhaled CO2 onconstricted airways in a rat model <strong>of</strong> allergic asthma and to determine themechanism <strong>of</strong> CO2-induced bronchial smooth muscle relaxation.An animal model <strong>of</strong> chronic asthma was developed using Brown Norway ratsimmunized and challenged with ovalbumin. Histologic examination <strong>of</strong> theairways showed most <strong>of</strong> the features <strong>of</strong> human asthma. <strong>The</strong> response to allergenand treatment was monitored using non-invasive whole body plethysmography.Inhaled CO2 caused a rapid, reversible and dose-dependent relaxation <strong>of</strong>constricted airways during the late phase <strong>of</strong> the asthmatic response. <strong>The</strong> percentdrop <strong>of</strong> the enhanced pause (an index <strong>of</strong> bronchoconstiction) was 6.9% ± 5.29,15.8% ± 5.83, 43.7% ± 6.37 and 68.5% ± 11.1 (mean ± SE) with 2%, 5%, 8%and 20% CO2 respectively. Arterial blood gases during the late phase responsein ovalbumin-challenged rats showed a significant increase in PaCO2,decreased arterial blood pH and decreased PaO2 compared with salinechallenged rats.CO2 caused rapid dose-dependent relaxation <strong>of</strong> constricted airways in anallergic model <strong>of</strong> asthma. Our results suggest that CO2 is a bronchial smoothmuscle relaxant and support the notion that hypocapnia (low PCO2) seen insome asthmatics may play a role in the pathogenesis <strong>of</strong> their asthma.P129Secondary vascular changes in pulmonary sequestrationsSS Desai 1 ,MDusmet 1 , G Ladas 1 , P Goldstraw 1 , AG Nicholson 11 Royal Brompton HospitalPulmonary sequestrations, both intralobar and extralobar, are localised lesionscomprising lung parenchyma receiving their blood supply via aberrant systemicarteries and lacking continuity with the upper respiratory tract. This studyretrospectively reviews parenchymal changes within 27 resected cases, inparticular concentrating on secondary vascular changes.All 27 cases (1982-<strong>2008</strong>) had H&E and EVG stains for review. <strong>The</strong>re were 11females and 16 males, with an age range <strong>of</strong> 2 months to 60 years (average = 13years). <strong>The</strong>re were 22 cases with intralobar and 5 cases with extralobarsequestration. A specific feeding vessel was identified in all but one extralobarcase. 15 <strong>of</strong> 27 cases showed intimal fibrosis and/or medial hypertrophycharacteristic <strong>of</strong> plexogenic changes in the pulmonary vasculature withadditional plexiform changes seen in 6 cases. Vascular changes such as medialhypertrophy were also seen within otherwise normal lung adjacent to the masslesions in 4/22 intralobar cases. In addition, one case each <strong>of</strong> dissection <strong>of</strong>systemic vessels and lymphangiomatosis were seen, both in extrapulmonarylesions. In terms <strong>of</strong> the parenchyma within the sequestations, 17 showedfeatures <strong>of</strong> type 2 congenital cystic adenomatoid lesions.Marked hypertensive vascular changes may be seen within the pulmonaryvessels in sequestrations with lesser changes more rarely seen in adjacent lung,likely due to prolonged increased pressure from the systemic blood supply. Inaddition, dissection and coexistent lymphangiomatosis are reported in theselesions.P128Frequency and significance <strong>of</strong> atypical histological features inpulmonary inflammatory my<strong>of</strong>ibroblastic tumoursN Etessami 1 ,MDusmet De Smours 1 , P Goldstraw 1 ,KThway 2 ,CFisher 2 ,ANicholson 11 Royal Brompton Hospital, London, 2 Royal Marsden Hospital, LondonInflammatory my<strong>of</strong>ibroblastic tumour (IMT) is a rare mesenchymal neoplasmwhich may present in many organs including lung. Tumour behaviour isunpredictable although the WHO states ‘intermediate biological potential’,However, some pulmonary cases are still being classified as inflammatorypseudotumour (IPT), a term that likely includes varying reactive mass lesionswith similar morphology, confounding prognostic data. Furthermore, withinIMTs overall, atypical features (high cellularity, rounded/large polygonal cells,abundant ganglion-like cells, necrosis and giant cells) and lack <strong>of</strong> ALK-1expression have recently been suggested to be associated with more aggressivebehaviour.We have retrospectively reviewed 38 cases reported as IPT, plasma cellgranuloma or IMT between 1992 and <strong>2008</strong>. Of these, 24 cases were classifiedas lesions other than IMT. In the remaining 14 cases, ages ranged from 5 to 70years with 8 females. Tumour sizes ranged between 11-110mm. All lesionsshowed ill-defined borders, with 8/14 showing extrapulmonary spread intoeither chest wall or mediastinal structures. 9/14 cases show atypical featuresincluding high cellularity, rounded/pleomorphic cells and necrosis, including allthose with extrapulmonary extension. Where tissue was available, 8/9 caseswere SMA positive. Staining for ALK-1 was negative in 4/4 cases, all <strong>of</strong> whichshowed atypical histological features, two with extrapulmonary extension.Pulmonary IMTs lack the frequency <strong>of</strong> ALK-1 expression seen in IMTspresenting at other sites and frequently show ‘atypical’ features that may beassociated with behaviour more aggressive than those presenting at other sites.P130Automated Scoring <strong>of</strong> Tissue Microarrays using Virtual SlidesAWright 1 ,DMagee 2 ,PQuirke 1 , D Treanor 11 Pathology and Tumour Biology, <strong>Leeds</strong> Institute <strong>of</strong> Molecular Medicine,University <strong>of</strong> <strong>Leeds</strong>, 2 School <strong>of</strong> Computing, University <strong>of</strong> <strong>Leeds</strong>Tissue microarrays (TMAs) are a widely used tool in medical research torapidly compare protein expression across hundreds <strong>of</strong> samples. Howeverscoring tissue microarrays with a conventional microscope is a laborious taskwhich is prone to error.Virtual slides are an excellent tool for capturing TMA images for later analysisas they allow manual scoring <strong>of</strong> TMAs at a computer console. Furthermore theyintroduce the possibility <strong>of</strong> rapid automatic scoring <strong>of</strong> entire tissue microarraysusing image analysis.We describe a system developed to automatically score immunohistochemicalstaining on tissue microarrays with virtual slides.<strong>The</strong> system analyses the slide at low resolution to identify cores (and identifiesdamaged or missing cores). It then analyses each core individually to calculatethe amount <strong>of</strong> positive staining in the tissue. <strong>The</strong> results are presented to theuser together with the virtual slide image <strong>of</strong> the cores for quality control andfurther study. This system has been used to score a TMA series <strong>of</strong> over 3,000cores in less than 24 hours, significantly faster than a human scorer would beable to achieve.64 <strong>Summer</strong> <strong>Meeting</strong> (194 th ) 1–4 July <strong>2008</strong> Scientific Programme
P131Immunophenotype <strong>of</strong> Ductal Carcinoma in Situ in BRCAGermline Mutation CarriersP Van Der Groep* 1 , PJ Van Diest* 1 , E Van Der Wall# 11 University Medical Centre Utrecht, *Dept <strong>of</strong> Pathology and #Division <strong>of</strong>Internal Medicine and Dermatology,<strong>The</strong> NetherlandsBackground: Germline BRCA1 related breast cancers have a distinctbasal/triple negative immunophenotype, and show EGFR and HIF1 expression.Little is known about the immunophenotype <strong>of</strong> precursor lesions in BRCA1/2germline mutation carriers. <strong>The</strong> aim <strong>of</strong> this study was to examine whether thischaracteristic phenotype is already present in the pre- invasive stage.Material and Methods: DCIS <strong>of</strong> 6 proven BRCA1 and 4 BRCA2 germlinemutation carriers were stained by immunohistochemistry for ER, PR, HER-2/neu, Ck5/6, Ck14, EGFR and Ki67.Results: 4/11 cases (36%) were ER positive, 0/7 (0%) were PR positive, 0/10(0%) were HER2 positive, 5/10 (50%) were CK5/6 positive, 1/9 (11%) wereCK14 positive, and 6/10 (60%) were EGFR positive. Mean percentage Ki67nuclear staining was 30% (range 0-100). <strong>The</strong>se percentages are similar to thosethat have been reported for invasive cancers in BRCA1/2 mutation carriers,except for ER that is generally even lower in BRCA1/2 related cancers.Discussion: DCIS in BRCA1/2 germline mutation carriers shows a so calledbasal immunophenotype with high proliferation and EGFR positivity similar tothat <strong>of</strong> invasive cancers in such patients. This may be useful to identify“BRCA-ness” in cases <strong>of</strong> DCIS in diagnostic pathology, and opens up newways for targeted therapy against EGFR to prevent development <strong>of</strong> invasivecancer in case <strong>of</strong> a germline mutation.P133Perinecrotic HIF-1 Expression and Necrosis PredictPrognosis in Patients with Endometrioid EndometrialCarcinomaLMS Seeber# 1 , N Horrée# 1 , P Van Der Groep* 1 ,RHM Verheijen# 1 , PJ Van Diest* 1 .1 University Medical Centre Utrecht, Departments <strong>of</strong> #SurgicalGynecology and Oncology, and *Pathology, <strong>The</strong> NetherlandsBackground. Hypoxia-inducible factor 1 (HIF-1) plays an essential role inthe adaptive response <strong>of</strong> cells to hypoxia, triggering biologic events associatedwith aggressive tumour behaviour. Hypoxia and its key regulator HIF-1 playan important role in endometrial carcinogenesis, but contradictory results havebeen published as to the prognostic value <strong>of</strong> HIF-1 expression in endometrialcarcinoma. We therefore re-evaluated the prognostic value <strong>of</strong> HIF-1expression in a large representative group <strong>of</strong> endometrioid endometrial cancerusing well-established methodology.Methods. In 98 patients with endometrioid endometrial cancer, expressionlevels <strong>of</strong> HIF-1 and p27 were analyzed by immunohistochemistry. Presence <strong>of</strong>necrosis, and type <strong>of</strong> HIF-1 expression (perinecrotic, diffuse, or mixed) werenoted.Results. Stage, grade and depth <strong>of</strong> invasion showed prognostic value asexpected. Indicators <strong>of</strong> poor prognosis were presence <strong>of</strong> necrosis (p=0.05) andperinecrotic type <strong>of</strong> HIF-1 expression (p=0.03). In patients with perinecrotictype <strong>of</strong> HIF-1 expression, high p27 expression was an additional prognosticfactor. In Cox regression, HIF-1 was an additional prognostic factor to stage.Conclusion. In patients with endometrioid endometrial cancer, necrosis andnecrosis related expression <strong>of</strong> HIF-1 are important prognostic factors. In view<strong>of</strong> the proposed role <strong>of</strong> hypoxia and HIF-1 in endometrial cancer, HIF-1 isthereby an attractive therapeutic target.P132Hypoxia-Inducible Factor 1a is Essential for Hypoxic p27Induction in Endometrioid Endometrial CarcinomaN Horrée# 1 ,EH Gort* 1 , P Van Der Groep* 1 , APM Heintz# 1 ,M Vooijs* 1 , PJ Van Diest* 11 University Medical Centre Utrecht, *Departments <strong>of</strong> Pathology and#Surgical Gynaecology and Oncology,<strong>The</strong> NetherlandsHypoxia-inducible factor 1 (HIF-1) plays an essential role in the cellularadaptive hypoxia response. <strong>The</strong> cyclin-dependent kinase inhibitor p27(Kip1) ishighly expressed in the normal endometrium but is lost during endometrialcarcinogenesis. However, in high-grade cancers, p27 re-expression is observed.We analysed the role <strong>of</strong> HIF-1 in hypoxia-induced expression <strong>of</strong> p27 inendometrial cancer. Paraffin-embedded specimens from 39 endometrioidendometrial carcinomas were immunohistochemically stained for HIF-1, p27,and Ki67. HEC1B, an endometrial carcinoma cell line, was cultured undernormoxic or hypoxic conditions in the presence or absence <strong>of</strong> transientlyexpressed shRNAs targeting HIF-1. Protein expression <strong>of</strong> p27 and HIF-1 wasassessed by western blotting.Immunohistochemical staining revealed perinecrotic HIF-1 expression in 67%<strong>of</strong> the cases and p27 staining centrally in the tumour islands, mostly aroundnecrosis, in 46% <strong>of</strong> the cases. In 50% <strong>of</strong> the tumours with perinecrotic HIF-1expression, p27 and HIF-1 perinecrotic/central co-localization was observed.Hypoxia-associated p27 expression showed less proliferation around necrosis.In HEC1B, p27 protein expression was induced by hypoxia. This induction wasabrogated by transient knockdown <strong>of</strong> HIF-1 using RNAi. Furthermore,hypoxia induced cell cycle arrest in HEC1B cells. We conclude that, inendometrioid endometrial carcinoma, p27 re-expression by hypoxia is HIF-1dependentand leads to cell cycle arrest. This may contribute to the survival <strong>of</strong>cancer cells in hypoxic parts <strong>of</strong> the tumour.P134Nitric oxide down-regulates expression <strong>of</strong> the haemoglobinhaptoglobinscavenger receptor (CD163) on human monocyte /macrophagesG Hutchins 1 ,PM Guyre 2 , NJ Goulding 31 Dept. Histopathology, <strong>Leeds</strong> Teaching Hospitals NHS Trust, <strong>Leeds</strong>, UK2 Dept. Microbiology and Immunology, Darmouth Medical School,Lebanon, NH, USA, 3 William Harvey Research Institute, Barts and <strong>The</strong>London, Queen Mary's School <strong>of</strong> Medicine and Dentistry, LondonNitric oxide (NO) mediates many effects on immune system function. Althoughexaggerated NO production is well-characterised in many pathological states,it’s effect on the expression and function <strong>of</strong> the haemoglobin-haptoglobinscavenger receptor (CD163) is unknown.Human monocytes were isolated by density centrifugation andsubsequently exposed in 18-24 hour cultures to the NO generator DETA-NONOate. Co-incubation with factors known to promote CD163 expressionwas also performed. Metalloproteinase inhibitors were utilised to assessshedding as possible regulatory mechanism. CD163 expression was quantifiedby flow cytometry with supernatant soluble CD163 concentrations determinedby ELISA. Post-incubatory cell viability was confirmed by metabolic capacityand CD14 expression. CD163 expression was also evaluated followingexposure to the guanylate cyclase activator 8-Br-cGMP.Nitric oxide downregulated monocyte CD163 expression by upto 70% atmaximal concentrations. Similar attenuation was observed following coexposureto both NO and interleukin-10 or dexamethasone. CD163 expressionwas downregulated by 24% through NO exposure following super-induction <strong>of</strong>CD163 expression by co-incubation with IL-10 and dexamethasone. Nitricoxide had no effect on cell viability but did induce a reduction in solubleCD163 detected in the culture supernatants relative to controls, thus excludingshedding as a downregulatory mechanism. <strong>The</strong> guanylate cyclase activator, 8-Br-cGMP, also induced downregulation <strong>of</strong> CD163, indicating a possible role <strong>of</strong>guanylyl cyclase in the downregulatory process.This study has established a role <strong>of</strong> nitric oxide in regulating expression <strong>of</strong>CD163, possibly through activation <strong>of</strong> guanylate cyclase.<strong>Summer</strong> <strong>Meeting</strong> (194 th ) 1–4 July <strong>2008</strong> Scientific Programme65